BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34281574)

  • 1. Comparing the monetary value of a quality-adjusted life year from the payment card and the open-ended format.
    Ye Z; Liu F; Ma J; Zhou Z; Wang C; Sun L
    Cost Eff Resour Alloc; 2021 Jul; 19(1):45. PubMed ID: 34281574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can a Circular Payment Card Format Effectively Elicit Preferences? Evidence From a Survey on a Mandatory Health Insurance Scheme in Tunisia.
    Chanel O; Makhloufi K; Abu-Zaineh M
    Appl Health Econ Health Policy; 2017 Jun; 15(3):385-398. PubMed ID: 27798795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay for a hearing aid: comparing the payment scale and open-ended question.
    Grutters JP; Anteunis LJ; Chenault MN; Joore MA
    J Eval Clin Pract; 2009 Feb; 15(1):91-6. PubMed ID: 19239587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
    Mavrodi A; Aletras V
    Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity.
    Mavrodi A; Aletras V; Spanou A; Niakas D
    Pharmacoecon Open; 2017 Dec; 1(4):291-300. PubMed ID: 29441505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to Pay for One Additional Quality Adjusted Life Year: A Population Based Survey from China.
    Ye Z; Abduhilil R; Huang J; Sun L
    Appl Health Econ Health Policy; 2022 Nov; 20(6):893-904. PubMed ID: 35934772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monetary value of health-a practical decision-making framework combining equity considerations and WTP.
    Ribarić E; Velić I; Bobinac A
    Eur J Health Econ; 2024 May; ():. PubMed ID: 38769211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliciting willingness to pay: comparing closed-ended with open-ended and payment scale formats.
    Frew EJ; Whynes DK; Wolstenholme JL
    Med Decis Making; 2003; 23(2):150-9. PubMed ID: 12693877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China.
    Huang L; Peng X; Sun L; Zhang D
    Cost Eff Resour Alloc; 2023 Jun; 21(1):37. PubMed ID: 37277820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
    Nimdet K; Ngorsuraches S
    BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Web Comparison of Three Contingent Valuation Techniques in Women of Childbearing Age: The Case of Ovulation Induction in Quebec.
    Dieng A; He J; Poder TG
    Interact J Med Res; 2020 Feb; 9(1):e13355. PubMed ID: 32027310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monetary Value of Quality-Adjusted Life Years (QALY) among Patients with Cardiovascular Disease: a Willingness to Pay Study (WTP).
    Moradi N; Rashidian A; Rasekh HR; Olyaeemanesh A; Foroughi M; Mohammadi T
    Iran J Pharm Res; 2017; 16(2):823-833. PubMed ID: 28979338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating a WTP-based value of a QALY: the 'chained' approach.
    Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
    Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay.
    Gyrd-Hansen D; Jensen ML; Kjaer T
    Health Econ; 2014 May; 23(5):550-63. PubMed ID: 23696155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the validity of the payment card and structured haggling willingness to pay methods: The case of a diabetes prevention program in rural Kenya.
    Kangethe A; Franic DM; Corso PS
    Soc Sci Med; 2016 Nov; 169():86-96. PubMed ID: 27701019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to pay for one quality-adjusted life year in Iran.
    Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
    Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the design of payment scales on the willingness to pay for health gains.
    Soeteman L; van Exel J; Bobinac A
    Eur J Health Econ; 2017 Jul; 18(6):743-760. PubMed ID: 27623946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Worth of a Quality-Adjusted Life-Year in Patients with Diabetes: An Investigation Study using a Willingness-to-Pay Method.
    Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
    Pharmacoecon Open; 2019 Sep; 3(3):311-319. PubMed ID: 30617954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
    Thavorncharoensap M; Teerawattananon Y; Natanant S; Kulpeng W; Yothasamut J; Werayingyong P
    Clinicoecon Outcomes Res; 2013; 5():29-36. PubMed ID: 23345984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.